(GEVO) Gevo - Ratings and Ratios
Aviation Fuel, Renewable Gas, Motor Fuels, Specialty Chemicals
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 79.3% |
| Value at Risk 5%th | 113% |
| Relative Tail Risk | -13.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -43.10 |
| CAGR/Max DD | -0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.523 |
| Beta | 1.375 |
| Beta Downside | 1.189 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.36% |
| Mean DD | 47.16% |
| Median DD | 48.64% |
Description: GEVO Gevo December 30, 2025
Gevo, Inc. (NASDAQ: GEVO) positions itself as a carbon-abatement company operating three business lines-Gevo, GevoFuels, and GevoRNG-focused on producing renewable aviation fuel, motor fuels, specialty chemicals, and renewable natural gas (RNG) from low-carbon feedstocks.
Key operational metrics (as of FY 2023) include a production capacity of roughly 30 million gallons of sustainable aviation fuel (SAF) per year and an RNG output of ~1.2 billion cubic feet, with the Verity platform providing third-party-verified lifecycle-analysis data to support ESG claims.
The company’s growth hinges on three macro drivers: (1) the U.S. Inflation Reduction Act’s 40 % tax credit for SAF, (2) increasing airline commitments to net-zero emissions, and (3) state-level RNG incentives that boost demand for methane-capture projects. A sensitivity analysis suggests that a 10 % reduction in the SAF tax credit would cut projected FY 2025 revenue by roughly $45 million, underscoring the policy-risk exposure.
For a deeper, data-driven assessment of GEVO’s valuation assumptions and scenario modeling, you may find the ValueRay research hub useful.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-45.1m TTM) > 0 and > 6% of Revenue (6% = 7.26m TTM) |
| FCFTA -0.13 (>2.0%) and ΔFCFTA 4.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 53.79% (prev 1334 %; Δ -1280 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.08 (>3.0%) and CFO -52.2m <= Net Income -45.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (232.7m) change vs 12m ago -2.82% (target <= -2.0% for YES) |
| Gross Margin 40.20% (prev 24.89%; Δ 15.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 18.76% (prev 2.58%; Δ 16.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.17 (EBITDA TTM -3.95m / Interest Expense TTM 14.0m) >= 6 (WARN >= 3) |
Altman Z'' -7.75
| (A) 0.09 = (Total Current Assets 136.7m - Total Current Liabilities 71.7m) / Total Assets 685.2m |
| (B) -1.21 = Retained Earnings (Balance) -827.8m / Total Assets 685.2m |
| warn (B) unusual magnitude: -1.21 — check mapping/units |
| (C) -0.05 = EBIT TTM -30.3m / Avg Total Assets 644.5m |
| (D) -3.92 = Book Value of Equity -825.4m / Total Liabilities 210.4m |
| Total Rating: -7.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.52
| 1. Piotroski 2.50pt |
| 2. FCF Yield -14.79% |
| 3. FCF Margin -70.89% |
| 4. Debt/Equity 0.36 |
| 5. Debt/Ebitda -24.09 |
| 6. ROIC - WACC (= -12.66)% |
| 7. RoE -9.49% |
| 8. Rev. Trend 91.57% |
| 9. EPS Trend 56.01% |
What is the price of GEVO shares?
Over the past week, the price has changed by -3.40%, over one month by -11.56%, over three months by -12.33% and over the past year by -11.95%.
Is GEVO a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the GEVO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.3 | 166.8% |
| Analysts Target Price | 5.3 | 166.8% |
| ValueRay Target Price | 2 | -2% |
GEVO Fundamental Data Overview January 03, 2026
P/B = 1.0336
P/EG = -0.01
Beta = 1.447
Revenue TTM = 120.9m USD
EBIT TTM = -30.3m USD
EBITDA TTM = -3.95m USD
Long Term Debt = 134.2m USD (from longTermDebt, last quarter)
Short Term Debt = 31.6m USD (from shortTermDebt, last quarter)
Debt = 167.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 95.2m USD (from netDebt column, last quarter)
Enterprise Value = 579.8m USD (484.6m + Debt 167.8m - CCE 72.6m)
Interest Coverage Ratio = -2.17 (Ebit TTM -30.3m / Interest Expense TTM 14.0m)
FCF Yield = -14.79% (FCF TTM -85.7m / Enterprise Value 579.8m)
FCF Margin = -70.89% (FCF TTM -85.7m / Revenue TTM 120.9m)
Net Margin = -37.33% (Net Income TTM -45.1m / Revenue TTM 120.9m)
Gross Margin = 40.20% ((Revenue TTM 120.9m - Cost of Revenue TTM 72.3m) / Revenue TTM)
Gross Margin QoQ = 29.38% (prev 60.23%)
Tobins Q-Ratio = 0.85 (Enterprise Value 579.8m / Total Assets 685.2m)
Interest Expense / Debt = 3.10% (Interest Expense 5.21m / Debt 167.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -23.9m (EBIT -30.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.91 (Total Current Assets 136.7m / Total Current Liabilities 71.7m)
Debt / Equity = 0.36 (Debt 167.8m / totalStockholderEquity, last quarter 468.9m)
Debt / EBITDA = -24.09 (negative EBITDA) (Net Debt 95.2m / EBITDA -3.95m)
Debt / FCF = -1.11 (negative FCF - burning cash) (Net Debt 95.2m / FCF TTM -85.7m)
Total Stockholder Equity = 475.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.00% (Net Income -45.1m / Total Assets 685.2m)
RoE = -9.49% (Net Income TTM -45.1m / Total Stockholder Equity 475.6m)
RoCE = -4.96% (EBIT -30.3m / Capital Employed (Equity 475.6m + L.T.Debt 134.2m))
RoIC = -3.87% (negative operating profit) (NOPAT -23.9m / Invested Capital 617.1m)
WACC = 8.79% (E(484.6m)/V(652.4m) * Re(10.98%) + D(167.8m)/V(652.4m) * Rd(3.10%) * (1-Tc(0.21)))
Discount Rate = 10.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.64%
Fair Price DCF = unknown (Cash Flow -85.7m)
EPS Correlation: 56.01 | EPS CAGR: 14.80% | SUE: 1.58 | # QB: 1
Revenue Correlation: 91.57 | Revenue CAGR: 492.7% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.05 | Chg30d=+0.026 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.16 | Chg30d=+0.034 | Revisions Net=+0 | Growth EPS=-12.6% | Growth Revenue=+30.7%
Additional Sources for GEVO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle